Cargando…
Inferior Vena Cava Anomalies with Portal Vein System Continuation Presenting as Portal Hypertension with a Long-term Follow-up
Inferior vena cava (IVC) anomalies, such as the absence of an intra-hepatic IVC or IVC hypoplasia, are rare. Usually, these anomalies are asymptomatic and cause few clinical issues. We herien report a 53-year-old woman with IVC anomalies who demonstrated both azygos and portal vein system continuati...
Autores principales: | Fukushima, Masanori, Miyaaki, Hisamitsu, Sasaki, Ryu, Haraguchi, Masafumi, Miuma, Satoshi, Ishimaru, Hideki, Hidaka, Masaaki, Okudaira, Sadayuki, Eguchi, Susumu, Futakuchi, Mitsuru, Kusano, Hironori, Kage, Masayoshi, Nakao, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725638/ https://www.ncbi.nlm.nih.gov/pubmed/32713916 http://dx.doi.org/10.2169/internalmedicine.4956-20 |
Ejemplares similares
-
Intractable Hepatic Encephalopathy with a Large Portosystemic Shunt Successfully Treated Using Shunt-preserving Disconnection of the Portal and Systemic Circulation
por: Haraguchi, Masafumi, et al.
Publicado: (2020) -
Most Cases of Cryptogenic Cirrhosis May Be Nonobese Nonalcoholic Steatohepatitis - Risk Factors of Liver Steatosis After Liver Transplantation for Cryptogenic Cirrhosis: A Retrospective Study
por: Fukushima, Masanori, et al.
Publicado: (2022) -
Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia
por: Kuwahara, Ai, et al.
Publicado: (2020) -
The impact of single-nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct-acting antiviral drugs for hepatitis C infection
por: Matsumoto, Kosuke, et al.
Publicado: (2022) -
Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma
por: Sasaki, Ryu, et al.
Publicado: (2022)